Study guide

Sepsis, SIRS, Neutropenic Infection, and Shock

OCN Oncology Certified Nurse Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: OCN Exam Orientation and Official Source Control

Official Sources and Credential Purpose Eligibility, Application, and Fees Exam Format, Scoring, Blueprint, and Generic Drugs PSI Scheduling, ATT, Test Day, and Results Blueprint-Based Study Plan and Readiness

2 Chapter 2: Care Continuum, Prevention, Survivorship, and End-of-Life Care

Health Promotion, Risk Reduction, and Epidemiology Screening, Early Detection, and High-Risk Referrals Navigation, Coordination, and Care Continuity Palliative Care, Advance Care Planning, and Goals Survivorship, Rehabilitation, Recurrence, and Late Effects Sexuality, Family Support, Discrimination, and Social Needs End-of-Life Care, Hospice, Bereavement, and Comfort Measures

3 Chapter 3: Oncology Science and Site-Specific Cancer Assessment

Carcinogenesis, Immunology, and Cancer Biology Genomic, Genetic Testing, and Biomarker Literacy Clinical Trials, Research Protocols, and Informed Participation Diagnostic Workup, Biopsy, Imaging, and Pathology Basics Staging, Grading, Prognosis, and Performance Status Common Cancer Patterns and Metastatic Sites Oncology Assessment, Data Clustering, and Escalation

4 Chapter 4: Professional Oncology Nursing Practice, Safety, and Standards

Scope, Standards, Nursing Process, and Documentation Collaboration, Communication, and Interprofessional Practice Safe Handling, PPE, Occupational Health, and Exposure Response Culturally Congruent Care, Advocacy, and Ethics Self-Care, Compassion Fatigue, Burnout, and Professional Development

5 Chapter 5: Treatment Modalities I - Surgery, Radiation, Transplant, Localized and Oral Therapy

Surgery and Procedural Oncology Nursing Care Radiation Therapy Principles, Toxicities, and Teaching Blood and Marrow Transplant Foundations Localized Therapy: Intrathecal, Intravesical, and Regional Care Oral Oncology Therapy Adherence, Safety, and Education Treatment Sequencing, Response Monitoring, and Care Coordination Modality-Specific Patient Teaching and Documentation

6 Chapter 6: Treatment Modalities II - Systemic Therapy, Immunotherapy, and Targeted Agents

Chemotherapy Foundations and Infusion Safety Biotherapy, Immunotherapy, and Immune-Related Adverse Events Targeted Therapy, Immune Cell, and Bispecific Antibody Basics Hormonal Therapy and Endocrine Cancer Treatment Considerations Vascular Access, Infusion Monitoring, and Extravasation Prevention Systemic Therapy Patient Education and Home Safety Therapy Response, Adherence, and Toxicity Escalation

7 Chapter 7: Symptom Management and Supportive Care

Symptom Assessment, Toxicity Grading, and Prioritization Hematologic, Immunologic, and Infection Supportive Care GI, GU, Nutrition, and Hydration Supportive Care Integumentary, Ostomy, Lymphedema, and Wound Care Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms Pain Management, Pharmacologic, and Integrative Care Vascular Access Device Care and Supportive Care Coordination

8 Chapter 8: Oncologic Emergencies and Rapid Escalation

Sepsis, SIRS, Neutropenic Infection, and Shock Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies Hypersensitivity, Anaphylaxis, and Infusion Reactions Spinal Cord Compression, SVC Syndrome, Increased ICP, and Obstructions DIC, VTE, Bleeding, and Thrombotic Emergencies Pneumonitis, Extravasation, and Local Therapy Emergencies Immune-Related Emergencies, CRS, ICANS, and Urgent Triage

9 Chapter 9: Psychosocial Dimensions of Oncology Care

Distress Screening, Emotional Response, and Crisis Care Cultural, Spiritual, Religious, and Language-Responsive Care Family, Caregiver Support, and Shared Decision-Making Sexuality, Fertility, Gender, and Body Image Concerns Learning Barriers, Health Literacy, and Patient Education Financial Toxicity, Support Systems, and Resource Referrals

10 Chapter 10: Mixed OCN Case Labs

New Diagnosis Navigation and Treatment Planning Case Lab Chemotherapy Infusion Reaction and Extravasation Case Lab Immunotherapy Toxicities and CRS ICANS Case Lab Radiation Surgery and Localized Therapy Case Lab Symptom Management Neutropenia Pain and Nutrition Case Lab Oncologic Emergency TLS SVC Cord Compression Case Lab Survivorship Palliative Psychosocial and Discharge Case Lab

11 Chapter 11: Final Review, High-Yield Tables, and OCN Exam-Day Readiness

Blueprint Quick Reference and Domain Triage High-Yield Oncology Safety and Emergency Tables Generic Drug Stems, Labs, and Supportive Care Patterns Final Week Practice Plan, Error Log, and Stamina Final 48 Hours, PSI Test Day, and Retake Planning

Sepsis, SIRS, Neutropenic Infection, and Shock

Key Takeaways Explain This Topic AI

Febrile neutropenia is defined as a single oral temperature of 38.3 C (101 F) or higher, or 38.0 C (100.4 F) or higher sustained one hour with an absolute neutrophil count (ANC) below 500 cells/mcL.

Severe neutropenia is ANC below 500 and profound neutropenia is ANC below 100; risk and infection severity rise as the ANC falls and as the neutropenic period lengthens.

Empiric broad-spectrum antibiotics should be started within 60 minutes of presentation; obtaining cultures must not delay that first dose.

Neutropenic patients often lack pus, erythema, and focal findings, so subtle signs such as low-grade fever, rigors, or new confusion may be the only warning of bacteremia.

The RN role is to recognize danger early, activate the sepsis or neutropenic-fever pathway, deliver ordered therapy fast, and reassess after every intervention.

Last updated: October 2026

Sepsis, SIRS, Neutropenic Infection, and Shock

Sepsis is life-threatening organ dysfunction from a dysregulated host response to infection, and it is a recurring OCN exam topic because oncology patients deteriorate faster and present more subtly than other adults. Neutropenia removes the inflammatory machinery that normally produces pus, focal tenderness, and visible redness, so a patient can be bacteremic and heading toward shock while a central-line exit site looks only mildly pink. The first clue may be a single low-grade fever, shaking chills (rigors), new confusion, anorexia, or unexplained tachycardia.

Quantifying the Risk: The Absolute Neutrophil Count

You must be able to read and act on the absolute neutrophil count (ANC) . Calculate it as: ANC = white blood cell count x (percent segmented neutrophils + percent bands) / 100. A WBC of 2.0 x 10^9/L with 20% segs and 5% bands gives an ANC of 500. Memorize these thresholds:

  • ANC (cells/mcL) Classification Implication
  • 1000 to 1500 Mild neutropenia Modest infection risk
  • 500 to 1000 Moderate neutropenia Rising risk; counsel precautions
  • Below 500 Severe neutropenia Febrile neutropenia is an emergency
  • Below 100 Profound neutropenia Highest sepsis and mortality risk

Febrile neutropenia is defined as a single oral temperature of 38.3 C (101 F) or higher, or a temperature of 38.0 C (100.4 F) or higher sustained for at least one hour, in a patient with an ANC below 500 (or expected to fall below 500 within 48 hours). Treat it as an emergency every time.

Early Recognition and the Sepsis Bundle

Never rely on antipyretics or a patient saying the fever has "broken" - acetaminophen masks fever and can delay care. Hypothermia is also a danger sign, especially in frail or older adults. Watch for the perfusion and compensation findings below.

  • Finding Why it matters
  • Fever, rigors, or hypothermia May be the only sign of infection in neutropenia
  • Tachycardia or tachypnea Early compensation for shock or hypoxia
  • Hypotension, dizziness, syncope Possible septic shock or dehydration
  • New confusion, lethargy, anxiety Hypoperfusion, hypoxia, or CNS infection
  • Oliguria, cool skin, mottling Poor perfusion and impending organ injury

The time-to-antibiotics target is the highest-yield fact here: empiric broad-spectrum antibiotics (commonly an antipseudomonal beta-lactam such as cefepime or piperacillin-tazobactam) should be infusing within 60 minutes. Obtain blood cultures from a peripheral site and each central lumen, plus urine and respiratory specimens when indicated, but do not let culture collection push the first dose past the goal.

Nursing Actions and Precautions

Verify allergies, assess airway, breathing, circulation, mental status, the temperature source, and vascular access. Notify the provider or rapid response team for any instability. Support perfusion with ordered isotonic fluids and oxygen, and track strict intake and output and lactate trends. In neutropenic patients, avoid rectal temperatures, suppositories, enemas, and digital rectal exams unless specifically directed, because mucosal trauma seeds bacteremia. Worked example: a post-chemotherapy patient with an ANC of 120 reports a 38.5 C temperature and a single rigor.

This meets febrile-neutropenia criteria - draw cultures, start antibiotics within the hour, begin fluids, and escalate; do not wait for a cough or a positive culture.

Patient Education and Handoff

Before any outpatient regimen, teach the patient to check temperature as directed and to call immediately for any fever of 38.0 C or higher or any shaking chills - and never to self-treat fever with acetaminophen or NSAIDs unless instructed, because doing so hides the warning sign and delays antibiotics. A frequent OCN trap is the well-appearing patient: feeling fine does not make a fever safe during neutropenia. Reinforce hand hygiene, food safety (avoid undercooked meats, unwashed produce, and soft cheeses), oral care, central-line care, and a clear after-hours number.

Escalation Triggers and Reassessment

Escalate immediately for hypotension, new confusion, dyspnea, falling oxygen saturation, rigors, uncontrolled fever, rising lactate, decreased urine output, chest pain, or a new rash with fever. Use a structured handoff: cancer diagnosis, last treatment date, current ANC, temperature pattern, vital-sign trends, suspected source, line status, allergies, cultures obtained, antibiotic start time, fluids given, urine output, and mental status.

Reassess after every intervention, not only after orders are completed - a patient whose blood pressure improves briefly after a fluid bolus but then drifts down again is still in shock and needs vasopressors and ICU evaluation. Septic shock is sepsis with vasopressor-requiring hypotension and a lactate above 2 mmol/L despite adequate fluids.

Special Sources in the Neutropenic Host

Know the high-yield sources of infection unique to oncology patients, because the source guides the workup. Central line-associated bloodstream infection is common; draw paired cultures from each lumen and the periphery and watch for chills timed to a line flush, which strongly suggests line infection. Neutropenic enterocolitis (typhlitis) presents with fever, right-lower-quadrant pain, and diarrhea in profoundly neutropenic patients and can perforate. Mucositis breaks the oral and gut barrier and seeds streptococcal and gram-negative bacteremia. Perirectal infection can be devastating yet show only pain and minimal swelling.

Fungal disease, including invasive aspergillosis and candidemia, becomes a concern with prolonged neutropenia beyond 7 to 10 days. Because the neutropenic patient cannot mount classic signs, a normal chest x-ray or a clean-looking line site never rules out infection. Discharge from an outpatient setting is inappropriate when the patient remains unstable, has unreliable follow-up, or cannot reliably obtain urgent antibiotics and monitoring at home; admission and continued empiric coverage are the safer path until the ANC recovers and the source is controlled.